Oncopharmpod
Amivantamab
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:12:30
- Mas informaciones
Informações:
Sinopsis
Discussing a first of its kind drug, amivantamab, a bispecific (MET & EGFR) monoclonal antibody just approved for advanced exon20 insertion NSCLC (2nd line).
